Gene symbol | WT1 | Synonyms | AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1, WT33 | Type of gene | protein-coding |
Chromosome | 11 | Map location | 11p13 | dbXrefs | |
Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
Description | WT1 transcription factor |
GTO ID | GTC0242 |
Trial ID | NCT02408016 |
Disease | Lung Non-Small Cell Carcinoma | Malignant Mesothelioma |
Altered gene | WT1 |
Therapeutic/Target gene | Target gene |
Therapy | TCR-T cell |
Treatment | WT1 TCR-T cells |
HLA | HLA-A*02:01 |
Phase | Phase1|Phase2 |
Recruitment status | Terminated |
Title | Phase I/II Study in WT1-Expressing Non-small Cell Lung Cancer and Mesothelioma, Comparing Cellular Adoptive Immunotherapy With Polyclonal Autologous Central Memory to Naïve CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T-Cell Receptor |
Year | 2015 |
Country | United States |
Company sponsor | Fred Hutchinson Cancer Research Center |
Other ID(s) | 2727.00|NCI-2015-00329|2727|2727.00|P30CA015704 |
Cohort1: infusion cyclophosphamide on days 11 and 12 | |||||||||||||
|
|||||||||||||
Cohort2: infusion cyclophosphamide on days -3 and -2 | |||||||||||||
|